300 related articles for article (PubMed ID: 20722764)
1. The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.
van Bergen J; Koning F
Immunology; 2010 Nov; 131(3):301-9. PubMed ID: 20722764
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.
Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M
Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492
[TBL] [Abstract][Full Text] [Related]
3. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
[TBL] [Abstract][Full Text] [Related]
4. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
5. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
[TBL] [Abstract][Full Text] [Related]
6. Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells.
Anfossi N; Doisne JM; Peyrat MA; Ugolini S; Bonnaud O; Bossy D; Pitard V; Merville P; Moreau JF; Delfraissy JF; Dechanet-Merville J; Bonneville M; Venet A; Vivier E
J Immunol; 2004 Dec; 173(12):7223-9. PubMed ID: 15585844
[TBL] [Abstract][Full Text] [Related]
7. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.
Béziat V; Liu LL; Malmberg JA; Ivarsson MA; Sohlberg E; Björklund AT; Retière C; Sverremark-Ekström E; Traherne J; Ljungman P; Schaffer M; Price DA; Trowsdale J; Michaëlsson J; Ljunggren HG; Malmberg KJ
Blood; 2013 Apr; 121(14):2678-88. PubMed ID: 23325834
[TBL] [Abstract][Full Text] [Related]
8. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M
J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437
[TBL] [Abstract][Full Text] [Related]
9. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.
Gumá M; Angulo A; Vilches C; Gómez-Lozano N; Malats N; López-Botet M
Blood; 2004 Dec; 104(12):3664-71. PubMed ID: 15304389
[TBL] [Abstract][Full Text] [Related]
10. The Yin and Yang of HLA and KIR in human disease.
Kulkarni S; Martin MP; Carrington M
Semin Immunol; 2008 Dec; 20(6):343-52. PubMed ID: 18635379
[TBL] [Abstract][Full Text] [Related]
11. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis.
Namekawa T; Snyder MR; Yen JH; Goehring BE; Leibson PJ; Weyand CM; Goronzy JJ
J Immunol; 2000 Jul; 165(2):1138-45. PubMed ID: 10878393
[TBL] [Abstract][Full Text] [Related]
12. Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I.
Schönberg K; Fischer JC; Kögler G; Uhrberg M
Blood; 2011 May; 117(19):5152-6. PubMed ID: 21415265
[TBL] [Abstract][Full Text] [Related]
13. HLA and KIR polymorphisms affect NK-cell anti-tumor activity.
Passweg JR; Huard B; Tiercy JM; Roosnek E
Trends Immunol; 2007 Oct; 28(10):437-41. PubMed ID: 17825623
[TBL] [Abstract][Full Text] [Related]
14. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
[TBL] [Abstract][Full Text] [Related]
15. Killer immunoglobulin-like receptors.
Moretta L; Moretta A
Curr Opin Immunol; 2004 Oct; 16(5):626-33. PubMed ID: 15342010
[TBL] [Abstract][Full Text] [Related]
16. From Chickens to Humans: The Importance of Peptide Repertoires for MHC Class I Alleles.
Kaufman J
Front Immunol; 2020; 11():601089. PubMed ID: 33381122
[TBL] [Abstract][Full Text] [Related]
17. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.
David G; Morvan M; Gagne K; Kerdudou N; Willem C; Devys A; Bonneville M; Folléa G; Bignon JD; Retière C
Immunology; 2009 Oct; 128(2):172-84. PubMed ID: 19740374
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.
Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW
Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654
[TBL] [Abstract][Full Text] [Related]
19. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis.
Yen JH; Moore BE; Nakajima T; Scholl D; Schaid DJ; Weyand CM; Goronzy JJ
J Exp Med; 2001 May; 193(10):1159-67. PubMed ID: 11369787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
